The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Bone Marrow Transplant-Global Market Insights and Sales Trends 2024

Bone Marrow Transplant-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1854764

No of Pages : 102

Synopsis
Bone marrow transplantation, also referred as hematopoietic stem cell transplantation is the process of replacing diseased or damaged bone marrow or bone marrow stem cells with healthy tissue. Bone marrow is a soft vascular tissue present in the interior of long bones, which is primarily responsible for hematopoiesis (formation of blood cells), production of lymphocytes, and storage of a fat. Bone marrow transplantation procedure is recommended to treat severe stages of leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia etc. 
The global Bone Marrow Transplant market size is expected to reach US$ 9928.2 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of Bone Marrow Transplant in various end use industries. The expanding demands from the Hospitals, Multispecialty Clinics and Ambulatory Surgical Centers,, are propelling Bone Marrow Transplant market. Autologous Bone Marrow Transplant, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Allogeneic Bone marrow Transplant segment is estimated at % CAGR for the next seven-year period.
Increasing worldwide prevalence of cancers and anemia is the major driver for the growth of global bone marrow transplant market. Moreover, advances in technology, improving healthcare infrastructure, emerging indications of bone marrow transplant for heart and neuronal disorders, growing investment in logistic services, increasing per capita healthcare expenditure are some other factors expected to flourish the global bone marrow transplantation market. However, tremendous cost of the treatment, scarcity of bone marrow donors and uncertainty of reimbursement in several countries are some major restraints for the growth of global bone marrow transplantation market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bone Marrow Transplant, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bone Marrow Transplant market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bone Marrow Transplant market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bone Marrow Transplant sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bone Marrow Transplant covered in this report include Merck Millipore Corporation, Sanofi-Aventis, AllCells, STEMCELL Technologies, ATCC, Hemacare Corporation, ReachBio, Conversant and PromoCell, etc.
The global Bone Marrow Transplant market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck Millipore Corporation
Sanofi-Aventis
AllCells
STEMCELL Technologies
ATCC
Hemacare Corporation
ReachBio
Conversant
PromoCell
Lifeline Cell Technology
Mesoblast
Global Bone Marrow Transplant market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bone Marrow Transplant market, Segment by Type:
Autologous Bone Marrow Transplant
Allogeneic Bone marrow Transplant
Global Bone Marrow Transplant market, by Application
Hospitals
Multispecialty Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bone Marrow Transplant companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Bone Marrow Transplant
1.1 Bone Marrow Transplant Market Overview
1.1.1 Bone Marrow Transplant Product Scope
1.1.2 Bone Marrow Transplant Market Status and Outlook
1.2 Global Bone Marrow Transplant Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bone Marrow Transplant Market Size by Region (2018-2029)
1.4 Global Bone Marrow Transplant Historic Market Size by Region (2018-2023)
1.5 Global Bone Marrow Transplant Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bone Marrow Transplant Market Size (2018-2029)
1.6.1 North America Bone Marrow Transplant Market Size (2018-2029)
1.6.2 Europe Bone Marrow Transplant Market Size (2018-2029)
1.6.3 Asia-Pacific Bone Marrow Transplant Market Size (2018-2029)
1.6.4 Latin America Bone Marrow Transplant Market Size (2018-2029)
1.6.5 Middle East & Africa Bone Marrow Transplant Market Size (2018-2029)
2 Bone Marrow Transplant Market by Type
2.1 Introduction
2.1.1 Autologous Bone Marrow Transplant
2.1.2 Allogeneic Bone marrow Transplant
2.2 Global Bone Marrow Transplant Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bone Marrow Transplant Historic Market Size by Type (2018-2023)
2.2.2 Global Bone Marrow Transplant Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bone Marrow Transplant Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bone Marrow Transplant Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bone Marrow Transplant Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bone Marrow Transplant Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bone Marrow Transplant Revenue Breakdown by Type (2018-2029)
3 Bone Marrow Transplant Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Multispecialty Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Bone Marrow Transplant Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bone Marrow Transplant Historic Market Size by Application (2018-2023)
3.2.2 Global Bone Marrow Transplant Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bone Marrow Transplant Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bone Marrow Transplant Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bone Marrow Transplant Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bone Marrow Transplant Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bone Marrow Transplant Revenue Breakdown by Application (2018-2029)
4 Bone Marrow Transplant Competition Analysis by Players
4.1 Global Bone Marrow Transplant Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bone Marrow Transplant as of 2022)
4.3 Date of Key Players Enter into Bone Marrow Transplant Market
4.4 Global Top Players Bone Marrow Transplant Headquarters and Area Served
4.5 Key Players Bone Marrow Transplant Product Solution and Service
4.6 Competitive Status
4.6.1 Bone Marrow Transplant Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck Millipore Corporation
5.1.1 Merck Millipore Corporation Profile
5.1.2 Merck Millipore Corporation Main Business
5.1.3 Merck Millipore Corporation Bone Marrow Transplant Products, Services and Solutions
5.1.4 Merck Millipore Corporation Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Millipore Corporation Recent Developments
5.2 Sanofi-Aventis
5.2.1 Sanofi-Aventis Profile
5.2.2 Sanofi-Aventis Main Business
5.2.3 Sanofi-Aventis Bone Marrow Transplant Products, Services and Solutions
5.2.4 Sanofi-Aventis Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi-Aventis Recent Developments
5.3 AllCells
5.3.1 AllCells Profile
5.3.2 AllCells Main Business
5.3.3 AllCells Bone Marrow Transplant Products, Services and Solutions
5.3.4 AllCells Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.3.5 STEMCELL Technologies Recent Developments
5.4 STEMCELL Technologies
5.4.1 STEMCELL Technologies Profile
5.4.2 STEMCELL Technologies Main Business
5.4.3 STEMCELL Technologies Bone Marrow Transplant Products, Services and Solutions
5.4.4 STEMCELL Technologies Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.4.5 STEMCELL Technologies Recent Developments
5.5 ATCC
5.5.1 ATCC Profile
5.5.2 ATCC Main Business
5.5.3 ATCC Bone Marrow Transplant Products, Services and Solutions
5.5.4 ATCC Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.5.5 ATCC Recent Developments
5.6 Hemacare Corporation
5.6.1 Hemacare Corporation Profile
5.6.2 Hemacare Corporation Main Business
5.6.3 Hemacare Corporation Bone Marrow Transplant Products, Services and Solutions
5.6.4 Hemacare Corporation Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.6.5 Hemacare Corporation Recent Developments
5.7 ReachBio
5.7.1 ReachBio Profile
5.7.2 ReachBio Main Business
5.7.3 ReachBio Bone Marrow Transplant Products, Services and Solutions
5.7.4 ReachBio Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.7.5 ReachBio Recent Developments
5.8 Conversant
5.8.1 Conversant Profile
5.8.2 Conversant Main Business
5.8.3 Conversant Bone Marrow Transplant Products, Services and Solutions
5.8.4 Conversant Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.8.5 Conversant Recent Developments
5.9 PromoCell
5.9.1 PromoCell Profile
5.9.2 PromoCell Main Business
5.9.3 PromoCell Bone Marrow Transplant Products, Services and Solutions
5.9.4 PromoCell Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.9.5 PromoCell Recent Developments
5.10 Lifeline Cell Technology
5.10.1 Lifeline Cell Technology Profile
5.10.2 Lifeline Cell Technology Main Business
5.10.3 Lifeline Cell Technology Bone Marrow Transplant Products, Services and Solutions
5.10.4 Lifeline Cell Technology Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.10.5 Lifeline Cell Technology Recent Developments
5.11 Mesoblast
5.11.1 Mesoblast Profile
5.11.2 Mesoblast Main Business
5.11.3 Mesoblast Bone Marrow Transplant Products, Services and Solutions
5.11.4 Mesoblast Bone Marrow Transplant Revenue (US$ Million) & (2018-2023)
5.11.5 Mesoblast Recent Developments
6 North America
6.1 North America Bone Marrow Transplant Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bone Marrow Transplant Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bone Marrow Transplant Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bone Marrow Transplant Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bone Marrow Transplant Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bone Marrow Transplant Market Dynamics
11.1 Bone Marrow Transplant Industry Trends
11.2 Bone Marrow Transplant Market Drivers
11.3 Bone Marrow Transplant Market Challenges
11.4 Bone Marrow Transplant Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’